Skip to content

Clinical trials

Phase 1/2 Hearing Loss trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hearing Loss Phase: Phase 1/2 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20121
20131
20151
20171
20181
20191
20202
20211
20231
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed5
Active, not recruiting2
Terminated2
Unknown status2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Akouos, Inc.1
Contineum Therapeutics1
George Washington University1
Hannover Medical School1
House Research Institute1
McGill University Health Centre/Research Institute of the McGill University Health Centre1
Nordmark Arzneimittel GmbH & Co. KG1
Otonomy, Inc.1
Regeneron Pharmaceuticals1
Sensorion1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hearing Loss18
Hearing Loss, Sensorineural8
Deafness5
Hearing Disorders4
Ear Diseases3
Hearing Loss, Hidden3
Hearing Loss, Noise-Induced3
Hearing Loss, Bilateral2
Meniere Disease2
Acidosis, Lactic1

Trials

Showing 76 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.